1 / 9

Late-stage chronic kidney disease market (CKD) - Market rese

Due to loss of patent for major brands in the late-stage chronic kidney disease (CKD) market, and the changing reimbursement environment across the six major markets (6MM), the CKD sales revenue is forecasted to decrease at a negative CAGR of 2.5% between 2012 and 2017. The late-stage CKD therapeutics market in the 6MM (US, France, Germany, Italy, Spain, and UK) will decline from USD 1.88 billion in 2012 to USD 1.66 billion by 2017. It is expected that the majority of sales in the will still come from the US (76%), with marginal increase in the 5EU’s share (24%) during 2012 to 2017.

sarahjohnsonn
Télécharger la présentation

Late-stage chronic kidney disease market (CKD) - Market rese

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Report: Opportunity Analyzer Late-Stage Chronic Kidney Disease (CKD) - Opportunity Analysis and Forecasts to 2017 Report Insights • The late-stage Chronic Kidney Disease (CKD) therapeutics market in the 6MM is forecasted to decline from USD 1.88 bn in 2012 to USD 1.66 bn in 2017, at a CAGR of -2.5% • This decline is attributed to the loss of patent protection for major brands and tightening reimbursement environment for oral treatments in dialysis patients • With the expected launch of three novel pipeline agents, the dialysis CKD market segment is due to become increasingly competitive by 2017, as these agents enter a heavily genericized market

  2. Report: Opportunity Analyzer Late-Stage Chronic Kidney Disease (CKD) - Opportunity Analysis and Forecasts to 2017 Report Coverage • Overview of late-stage CKD, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management • Top line late-stage CKD therapeutics market revenue from 2012-2017 • Annual cost of therapy, and major marketed and pipeline drug sales in this forecast period are included • Key topics covered include strategic competitor assessment, market characterization, unmet needs, R&D strategies, and clinical trial design for the late-stage CKD therapeutics market • Pipeline analysis of comprehensive data split across different phases, emerging novel trends under development

  3. Report: Opportunity Analyzer Late-Stage Chronic Kidney Disease (CKD) - Opportunity Analysis and Forecasts to 2017 Report Coverage (Continued) • Synopses of innovative early-stage projects and detailed analysis of late-stage pipeline drugs • Analysis of the current and future market competition in the global late-stage CKD therapeutics market • Insightful review of the key industry drivers, restraints and challenges • Each trend is independently researched to provide qualitative analysis of its implications

  4. Report: Opportunity Analyzer Late-Stage Chronic Kidney Disease (CKD) - Opportunity Analysis and Forecasts to 2017 Report Benefits • Develop and design in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline • Develop business strategies by understanding the trends shaping and driving the global late-stage CKD therapeutics market • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global late-stage CKD therapeutics market in the future • Formulate effective sales and marketing strategies

  5. Report: Opportunity Analyzer Late-Stage Chronic Kidney Disease (CKD) - Opportunity Analysis and Forecasts to 2017 Report Benefits (Continued) • Understand the competitive landscape by analysing the performance of various competitors • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage • Organize sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships

  6. Report: Opportunity Analyzer Late-Stage Chronic Kidney Disease (CKD) - Opportunity Analysis and Forecasts to 2017 Table of Contents • Introduction  • Disease Overview • Epidemiology  • Current Treatment Options • Unmet Needs Assessment and Opportunity Analysis • R&D Strategies • Pipeline Assessment • Pipeline Valuation Analysis • Appendix 

  7. Report: Opportunity Analyzer Late-Stage Chronic Kidney Disease (CKD) - Opportunity Analysis and Forecasts to 2017 Report Details • Publish date:15th Nov, 2013 • Number of slides: 226 • Geographic coverage: Global • Available format: PDF, CD, Hardcopy • Price for Single User License: USD 5,995 • Price for Site License: USD 11,990 • Price for Global User License: USD 17,985 • Delivery Time: Within 1 business day • Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal

  8. Interested in this report? To view more details regarding this premium market research report, Please click here For further information, get in touch with us: E-mail: support@researchonglobalmarkets.com Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports

More Related